Literature DB >> 17679094

APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase.

Virginia Amador1, Sheng Ge, Patricia G Santamaría, Daniele Guardavaccaro, Michele Pagano.   

Abstract

During the G1/S transition, p21 proteolysis is mediated by Skp2; however, p21 reaccumulates in G2 and is degraded again in prometaphase. How p21 degradation is controlled in mitosis remains unexplored. We found that Cdc20 (an activator of the ubiquitin ligase APC/C) binds p21 in cultured cells and identified a D box motif in p21 necessary for APC/C(Cdc20)-mediated ubiquitylation of p21. Overexpression of Cdc20 or Skp2 destabilized wild-type p21; however, only Skp2, but not Cdc20, was able to destabilize a p21(D box) mutant. Silencing of Cdc20 induced an accumulation of p21, increased the fraction of p21 bound to Cdk1, and inhibited Cdk1 activity in p21(+/+) prometaphase cells, but not in p21(-/-) cells. Thus, in prometaphase Cdc20 positively regulates Cdk1 by mediating the degradation of p21. We propose that the APC/C(Cdc20)-mediated degradation of p21 contributes to the full activation of Cdk1 necessary for mitotic events and prevents mitotic slippage during spindle checkpoint activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17679094      PMCID: PMC2000825          DOI: 10.1016/j.molcel.2007.06.013

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  56 in total

1.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

Authors:  A C Carrano; E Eytan; A Hershko; M Pagano
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

Review 2.  Stabilizers and destabilizers controlling cell cycle oscillators.

Authors:  Daniele Guardavaccaro; Michele Pagano
Journal:  Mol Cell       Date:  2006-04-07       Impact factor: 17.970

3.  In vivo ubiquitination and proteasome-mediated degradation of p53(1).

Authors:  C G Maki; J M Huibregtse; P M Howley
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

4.  Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation.

Authors:  C G Maki; P M Howley
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

5.  Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication.

Authors:  A B Niculescu; X Chen; M Smeets; L Hengst; C Prives; S I Reed
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

6.  Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition.

Authors:  V Dulić; G H Stein; D F Far; S I Reed
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  Cyclin is degraded by the ubiquitin pathway.

Authors:  M Glotzer; A W Murray; M W Kirschner
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

8.  Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21.

Authors:  T Waldman; C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

9.  N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.

Authors:  Philippe Coulombe; Geneviève Rodier; Eric Bonneil; Pierre Thibault; Sylvain Meloche
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

10.  Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.

Authors:  Y Li; C W Jenkins; M A Nichols; Y Xiong
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

View more
  114 in total

Review 1.  Structural insights into anaphase-promoting complex function and mechanism.

Authors:  David Barford
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

2.  Degradation of the human mitotic checkpoint kinase Mps1 is cell cycle-regulated by APC-cCdc20 and APC-cCdh1 ubiquitin ligases.

Authors:  Yongping Cui; Xiaolong Cheng; Ce Zhang; Yanyan Zhang; Shujing Li; Chuangui Wang; Thomas M Guadagno
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 3.  DNA replication licensing control and rereplication prevention.

Authors:  Chonghua Li; Jianping Jin
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

4.  APC/C(Cdc20) targets E2F1 for degradation in prometaphase.

Authors:  Melissa J Peart; Masha V Poyurovsky; Elizabeth M Kass; Marshall Urist; Emmy W Verschuren; Matthew K Summers; Peter K Jackson; Carol Prives
Journal:  Cell Cycle       Date:  2010-10-26       Impact factor: 4.534

5.  Targeting p21 degradation locally.

Authors:  Yue Xiong
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

6.  RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.

Authors:  Zehua Wang; Zhi Nie; Wenlin Chen; Zhongmei Zhou; Qinghua Kong; Arun K Seth; Rong Liu; Ceshi Chen
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

Review 7.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

8.  Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment.

Authors:  Débora Rosa Bublik; Massimiliano Scolz; Gianluca Triolo; Martín Monte; Claudio Schneider
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

Review 9.  The multiple layers of ubiquitin-dependent cell cycle control.

Authors:  Katherine Wickliffe; Adam Williamson; Lingyan Jin; Michael Rape
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

10.  14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer.

Authors:  Bing Wang; Kang Liu; Hui-Yi Lin; Naresh Bellam; Shiyun Ling; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.